RxDoctor Payments DataLook up a doctor →

Michelle Devoll

Nurse Practitioner · Zanesville, OHNPI 1023520327

Payments from drug & device makers

$9,561in general payments, 2019–2025

Across 647 payments — averaging $14.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$1K
  • Boehringer Ingelheim$604
  • Amgen$448
  • Lilly USA, LLC$399
  • GSK$380
  • plus $4K from 52 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)177$2,324
AstraZeneca(2 entities)87$1,416
Boehringer Ingelheim45$604
Amgen36$448
Lilly USA, LLC29$399
GSK26$380
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)15$367
Pfizer23$302
Exact Sciences13$249
Merck17$234
Lundbeck LLC13$228
Takeda Pharmaceuticals U.S.A., Inc.12$188
Novo Nordisk13$182
Otsuka America Pharmaceutical, Inc.10$178
Astellas Pharma US Inc9$178
Phathom Pharmaceuticals, Inc.8$148
Sanofi-aventis U.S. LLC10$133
Bayer8$132
Johnson & Johnson8$108
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC8$105
Sumitomo Pharma America, Inc.5$99
Novartis6$92
E.r. Squibb & Sons, L.L.C.6$87
Edwards Lifesciences4$85
Daiichi Sankyo Inc.5$72
Kowa Pharmaceuticals America, Inc.5$68
Radius Health, Inc.3$56
Medtronic3$53
Supernus Pharmaceuticals, Inc.3$50
Biohaven Pharmaceutical Holding Company Ltd.3$46
IBSA Pharma Inc.3$44
Jazz Pharmaceuticals Inc.3$38
Mylan Specialty L.p.2$38
Axsome Therapeutics, Inc.2$35
Urovant Sciences Inc2$31
Boston Scientific1$30
Teva Pharmaceuticals USA, Inc.2$27
Seqirus USA Inc1$21
Abiomed1$20
Paratek Pharmaceuticals, Inc.1$18
Alkermes, Inc.1$16
Dexcom, Inc.1$16
Biohaven Pharmaceuticals, Inc.1$16
Esperion Therapeutics, Inc.1$16
Vivus LLC1$15
Sun Pharmaceutical Industries Inc.1$15
Shield Therapeutics Inc1$15
Corcept Therapeutics1$15
Vivaquant Inc, Dba Rhythm Express1$14
Xeris Pharmaceuticals, Inc.1$14
GRT US Holding, Inc.1$14
Lucid Diagnostics Inc.1$13
Genentech USA, Inc.2$13
Avanir Pharmaceuticals, Inc.1$13
Philips North America LLC1$12
Hologic Sales And Service, LLC1$12
Organon1$11
Clarus Therapeutics Inc.1$10

How this compares

$9,561 in reported general payments places this provider in the 95th percentile of 4,700 nurse practitioner providers in Ohio.

See all nurse practitioner providers in Ohio

Medicare billing

Part B allowed, 2024
$76,733
Medicare patients
288
Services billed
1,358

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Zanesville

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →